YCBD Stock Analysis: Buy, Sell, or Hold?
YCBD - cbdMD, Inc. Common Stock
$0.74
0.08 (12.77%)
▲
5d:
-3.5%
30d:
-8.62%
90d:
-45.44%
BUY
HIGH Confidence
Analysis Updated: Mar 31, 2026 12:00 AM ET
Earnings: May 21, 2026
Get Alerted When YCBD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: YCBD shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: YCBD shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: YCBD is currently trading at $0.74, which is considered fair relative to its 30-day fair value range of $0.69 to $0.88.
Technical Outlook: Technically, YCBD is showing sideways momentum. Immediate support is located at $0.63, while resistance sits at $0.82. The stock is showing strong short-term momentum, up 12.8% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.00 (+204.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, YCBD is showing sideways momentum. Immediate support is located at $0.63, while resistance sits at $0.82. The stock is showing strong short-term momentum, up 12.8% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.00 (+204.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$0.69 -
$0.88
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+12.8%)
- BULLISH: Trading 204.0% below Wall St target ($2.00)
Fair Price Analysis
30-Day Fair Range
$0.69 -
$0.88
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$0.63
Resistance Level
$0.82
Current Trend
Sideways
Technical data as of
Mar 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.29
Wall Street Target
$2.00
(+204.0%)
Revenue Growth (YoY)
-11.0%
Profit Margin
-8.0%
Share & Embed Analysis
Last updated: March 31, 2026 3:49 PM ET
Data refreshes hourly during market hours. Next update: 4:49 PM
Data refreshes hourly during market hours. Next update: 4:49 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is YCBD showing a specific setup today?
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$178 | 64 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$151 | 58 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$91 | 57 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 65 BUY |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 65 BUY |
